None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Male and female adults aged 60 years or older (2) Patients who are able to communicate sufficiently with the researcher (3) Patients who have voluntarily provided written informed consent to participate in the clinical study
Exclusion criteria
Exclusion criteria: (1) Patients with tremor symptoms due to neurological diseases such as Parkinson’s disease or multiple sclerosis (2) Patients with Alzheimer’s disease or psychiatric disorders that prevent compliance with clinical study requirements (3) Patients with implanted cardiac pacemakers or defibrillators, making it difficult to perform multi-frequency bioelectrical impedance analysis (4) Patients with loss of arm/hand/thumb, paralysis of the hand, or those with casts/bandages on the hand or wrist, making grip strength measurement difficult (5) Female participants who are pregnant (6) Patients with progressive or currently treated malignant tumors (cancer) (including chemotherapy, radiation therapy, immunotherapy), or those with limitations in daily activities due to chronic obstructive pulmonary disease (COPD), moderate or severe asthma, or those receiving renal replacement therapy such as dialysis due to chronic kidney disease (7) Patients with other physical functional limitations that make it difficult to diagnose sarcopenia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of sarcopenia | — |
Secondary
| Measure | Time frame |
|---|---|
| Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F);Calf circumference;Handgrip Strength Test;5-Time Chair Stand Test;6-Meter Gait Speed Test;Bioelectrical Impedance Analysis | — |
Countries
Korea, Republic of
Contacts
Pusan National University Korean Medicine Hospital